newsfilter
← Latest News
GlobeNewswire·

KemPharm to Participate in the 2022 Joint NNPDF-INPDA Conference and Meeting

CELEBRATION, Fla., July 26, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH) (KemPharm, or the Company), a specialty pharmaceutical company focused on the discovery, development and commercialization of novel treatments for rare central nervous s